INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221,955 | -98.5% | 4,261 | -98.1% | 0.00% | -97.8% |
| Q2 2023 | $14,534,220 | +4112.8% | 229,536 | +2155.0% | 0.04% | +2150.0% |
| Q1 2021 | $345,000 | -13.8% | 10,179 | -60.8% | 0.00% | -33.3% |
| Q1 2020 | $400,000 | -84.3% | 26,000 | -86.8% | 0.00% | -66.7% |
| Q2 2019 | $2,555,000 | -13.7% | 196,803 | -19.0% | 0.01% | -18.2% |
| Q1 2019 | $2,960,000 | +30.1% | 243,003 | +21.6% | 0.01% | +10.0% |
| Q4 2018 | $2,276,000 | -65.3% | 199,803 | -33.9% | 0.01% | -58.3% |
| Q3 2018 | $6,561,000 | +12.8% | 302,348 | -8.1% | 0.02% | 0.0% |
| Q2 2018 | $5,814,000 | +27.4% | 329,048 | +51.8% | 0.02% | +14.3% |
| Q1 2018 | $4,563,000 | – | 216,759 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |